Statement of Principles concerning symptomatic Epstein-Barr virus infection No. 25 of 1998 (Cth)
Instrument No.25 of 1998
Determination
of
Statement of Principles
concerning
SYMPTOMATIC EPSTEIN-BARR VIRUS INFECTION
ICD CODE: 075
Veterans’ Entitlements Act 1986
This Statement of Principles is determined by the Repatriation Medical Authority under subsection 196B(2) of the Veterans’ Entitlements Act 1986 (the Act).
Kind of injury, disease or death
(a) This Statement of Principles is about symptomatic Epstein-Barr virus infection and death from symptomatic Epstein-Barr virus infection.
(b) For the purposes of this Statement of Principles, “symptomatic Epstein-Barr virus infection” means a clinical illness compatible with Epstein-Barr virus infection accompanied by serological evidence of recently acquired Epstein-Barr virus infection, attracting ICD code 075.
Basis for determining the factors
The Repatriation Medical Authority is of the view that there is sound medical-scientific evidence that indicates that symptomatic Epstein-Barr virus infection and death from symptomatic Epstein-Barr virus infection can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces.
Factors that must be related to service
Subject to clause 6, at least one of the factors set out in clause 5 must be related to any relevant service rendered by the person.
Factors
The factors that must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting symptomatic Epstein-Barr virus infection or death from symptomatic Epstein-Barr virus infection with the circumstances of a person’s relevant service are:
(a) having physical contact involving exchange of oral secretions with an individual infected with Epstein-Barr virus, at least 21 days, but not more than 49 days, immediately before the clinical onset of symptomatic Epstein-Barr virus infection; or
(b) having received a transfusion of blood or blood products, a bone marrow transplantation or other organ transplantation at least 21 days, but not more than 49 days, immediately before the clinical onset of symptomatic Epstein-Barr virus infection; or
(c) suffering from an immunodeficiency state at the time of the clinical worsening of symptomatic Epstein-Barr virus infection; or
(d) inability to obtain appropriate clinical management for symptomatic Epstein-Barr virus infection.
Factors that apply only to material contribution or aggravation
Paragraphs 5(c) to 5(d) apply only to material contribution to, or aggravation of, symptomatic Epstein-Barr virus infection where the person’s symptomatic Epstein-Barr virus infection was suffered or contracted before or during (but not arising out of) the person’s relevant service; paragraph 8(1)(e), 9(1)(e), 70(5)(d) or 70(5A)(d) of the Act refers.
Other definitions
For the purposes of this Statement of Principles:
“ICD code” means a number assigned to a particular kind of injury or disease in the Australian Version of The International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM), effective date of 1 July 1996, copyrighted by the National Coding Centre, Faculty of Health Sciences, University of Sydney, NSW, and having ISBN 0 642 24447 2;
“immunodeficiency state” means a pathological state where the immune response has been attenuated. Acquired immunodeficiency state occurs during or immediately following the administration of a course of immunosuppressive drugs, or whole body irradiation, and in the presence of human immunodeficiency virus (HIV) infection, severe protein-calorie malnutrition, or a systemic malignancy;
“other organ transplantation” means transplantation of organs such as kidneys, liver, heart and lungs. It does not include transplantation of avascular donor tissue such as corneal grafts;
“relevant service” means:
(a) operational service; or
(b) peacekeeping service; or
(c) hazardous service.
Dated this Fifth day of May 1998
The Common Seal of the )
Repatriation Medical Authority )
was affixed to this instrument )
in the presence of )
KEN DONALD
CHAIRMAN
0
0
0